person · Reporting owner

Bertolini Mark T

Disclosed activity across 4 companies

Tapewire entity: 14776
SEC CIK: 0001352552

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
CVS HEALTH CorpCVS · Entity 2884	Director	November 20, 2019	November 22, 2019
Oscar Health, Inc.OSCR · Entity 3582	Director · Chief Executive Officer	June 29, 2026	July 01, 2026
VERIZON COMMUNICATIONS INCVZ · Entity 116	Director	April 01, 2026	April 02, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CVS HEALTH Corp

Report date November 20, 2019 · Filed November 22, 2019

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	13,773	Reported balance After 2019-11-20 transaction · row 1 1 source row Row 1 · 2019-11-20 · Grant · Acquired 1,551 · Balance 13,773 F1: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.
Common StockSEC Table I · non-derivative	IndirectBy CLAT	100,072	Reported balance Holding disclosure · report date 2019-11-20 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 100,072 F2: Represents shares held in Charitable Lead Annuity Trust for which the reporting person is the investment advisor.

Filing footnotes · ownership attribution and instrument terms

F1: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan.

F2: Represents shares held in Charitable Lead Annuity Trust for which the reporting person is the investment advisor.

Oscar Health, Inc.

Report date June 29, 2026 · Filed July 01, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	7,751,570	Last balance in matching sequence After 2026-06-30 transaction · row 4 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 4 source rows Row 1 · 2026-06-29 · Sale · Disposed 555,826 · Balance 8,434,740 F1: Represents sale of shares to satisfy tax withholding obligations in connection with the deferred settlement of performance stock units that vested on April 3, 2026. The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on November 10, 2025 and amended and restated on March 24, 2026. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.74 to $29.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F3: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Row 2 · 2026-06-29 · Sale · Disposed 58,926 · Balance 8,375,814 F1: Represents sale of shares to satisfy tax withholding obligations in connection with the deferred settlement of performance stock units that vested on April 3, 2026. The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on November 10, 2025 and amended and restated on March 24, 2026. F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.74 to $30.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F3: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Row 3 · 2026-06-30 · Sale · Disposed 488,654 · Balance 7,887,160 F1: Represents sale of shares to satisfy tax withholding obligations in connection with the deferred settlement of performance stock units that vested on April 3, 2026. The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on November 10, 2025 and amended and restated on March 24, 2026. F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.78 to $28.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F3: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Row 4 · 2026-06-30 · Sale · Disposed 135,590 · Balance 7,751,570 F1: Represents sale of shares to satisfy tax withholding obligations in connection with the deferred settlement of performance stock units that vested on April 3, 2026. The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on November 10, 2025 and amended and restated on March 24, 2026. F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.78 to $29.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. F3: Includes shares to be issued in connection with the vesting of one or more restricted stock units.

Filing footnotes · ownership attribution and instrument terms

F1: Represents sale of shares to satisfy tax withholding obligations in connection with the deferred settlement of performance stock units that vested on April 3, 2026. The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on November 10, 2025 and amended and restated on March 24, 2026.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.74 to $29.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

F3: Includes shares to be issued in connection with the vesting of one or more restricted stock units.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.74 to $30.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.78 to $28.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.78 to $29.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

VERIZON COMMUNICATIONS INC

Report date April 01, 2026 · Filed April 02, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Phantom StockSEC Table II · derivative / convertible security	IndirectBy Deferred Compensation Plan	66,759	Reported balance After 2026-04-01 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-04-01 · Grant · Acquired 5,062 · Balance 66,759 F1: Each share of phantom stock is the economic equivalent of one share of common stock and is settled in cash. The shares of phantom stock become payable following the reporting person's termination of service as a director. F2: Includes phantom stock acquired through dividend reinvestment.

Filing footnotes · ownership attribution and instrument terms

F1: Each share of phantom stock is the economic equivalent of one share of common stock and is settled in cash. The shares of phantom stock become payable following the reporting person's termination of service as a director.

F2: Includes phantom stock acquired through dividend reinvestment.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

AETNA INC /PA/

Report date November 28, 2018 · Filed November 28, 2018

Section 16 reporting ended · disclosed 2018-11-28. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Ending reported balance After 2018-11-28 transaction · row 8 8 source rows · reconciled sequence Row 1 · 2018-11-28 · Exercise / conversion · Acquired 72,500 · Balance 124,037 F1: Vesting of performance stock units ("PSUs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") on February 19, 2016. Row 2 · 2018-11-28 · Exercise / conversion · Acquired 32,331 · Balance 156,368 F2: Vesting of PSUs granted under the Plan on February 17, 2017. Row 3 · 2018-11-28 · Exercise / conversion · Acquired 8,893 · Balance 165,261 F3: Vesting of previously reported restricted stock units ("RSUs") granted under the Plan on February 19, 2016. Row 4 · 2018-11-28 · Exercise / conversion · Acquired 13,220 · Balance 178,481 F4: Vesting of previously reported RSUs granted under the Plan on February 17, 2017. Row 5 · 2018-11-28 · Exercise / conversion · Acquired 17,572 · Balance 196,053 F5: Vesting of previously reported RSUs granted under the Plan on March 2, 2018. Row 6 · 2018-11-28 · Exercise / conversion · Acquired 76,044 · Balance 272,097 F5: Vesting of previously reported RSUs granted under the Plan on March 2, 2018. Row 7 · 2018-11-28 · Tax withholding · Disposed 102,990 · Balance 169,107 F6: Represents tax withholding on accelerated vesting of PSUs and RSUs granted under the Plan. Row 8 · 2018-11-28 · Disposition to issuer · Disposed 169,107 · Balance 0 F7: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock.
Common StockSEC Table I · non-derivative	IndirectBy CLAT	Reported balance After 2018-11-28 transaction · row 9 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 9 · 2018-11-28 · Disposition to issuer · Disposed 119,447 · Balance 0 F7: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. F8: Represents shares held in Charitable Lead Annuity Trust ("CLAT") for which Reporting Person is the investment advisor.
Common StockSEC Table I · non-derivative	IndirectBy 2017 GRAT	Reported balance After 2018-11-28 transaction · row 10 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 10 · 2018-11-28 · Disposition to issuer · Disposed 107,098 · Balance 0 F9: On August 27, 2018, 51,537 shares were voluntarily transferred from 2017 Grantor Retained Annuity Trust ("GRAT") to the Reporting Person's sole account. F7: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. F10: Represents shares held by 2017 GRAT for which Reporting Person is sole trustee.
Common StockSEC Table I · non-derivative	IndirectBy 2017 GRAT II	Reported balance After 2018-11-28 transaction · row 11 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 11 · 2018-11-28 · Disposition to issuer · Disposed 107,576 · Balance 0 F7: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. F11: Represents shares held by 2017 GRAT II for which Reporting Person is sole trustee.
Common StockSEC Table I · non-derivative	IndirectBy 2018 GRAT	Reported balance After 2018-11-28 transaction · row 12 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 12 · 2018-11-28 · Disposition to issuer · Disposed 259,969 · Balance 0 F12: On July 23, 2018, 145,826 shares were distributed to the Reporting Person's sole account to satisfy 2016 GRAT annuity obligation. On July 31, 2018, 259,969 shares were voluntarily transferred from Reporting Person's sole account to 2018 GRAT. F7: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. F13: Represents shares held by 2018 GRAT for which Reporting Person is sole trustee
Common StockSEC Table I · non-derivative	IndirectBy 2016 Trust	Reported balance After 2018-11-28 transaction · row 13 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 13 · 2018-11-28 · Disposition to issuer · Disposed 134,649 · Balance 0 F14: On October 24, 2018, 134,649 shares were transferred from 2016 GRAT to 2016 Trust. F7: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. F15: Represents shares held by a 2016 Trust for which Reporting Person is the investment advisor.
Common StockSEC Table I · non-derivative	IndirectBy 2018 Trust	Reported balance After 2018-11-28 transaction · row 14 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 14 · 2018-11-28 · Disposition to issuer · Disposed 14,961 · Balance 0 F16: On October 24, 2018, 14,961 shares were transferred from 2016 GRAT to 2018 Trust. F7: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. F17: Represents shares held by a 2018 Trust for which Reporting Person is the investment advisor.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2018-11-28 transaction · row 15 Instrument identity requires review; Table II rows are not merged. 1 source row Row 15 · 2018-11-28 · Exercise / conversion · Disposed 8,893 · Balance 0 F3: Vesting of previously reported restricted stock units ("RSUs") granted under the Plan on February 19, 2016.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2018-11-28 transaction · row 16 Instrument identity requires review; Table II rows are not merged. 1 source row Row 16 · 2018-11-28 · Exercise / conversion · Disposed 13,220 · Balance 0 F4: Vesting of previously reported RSUs granted under the Plan on February 17, 2017.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2018-11-28 transaction · row 17 Instrument identity requires review; Table II rows are not merged. 1 source row Row 17 · 2018-11-28 · Exercise / conversion · Disposed 17,572 · Balance 0 F5: Vesting of previously reported RSUs granted under the Plan on March 2, 2018.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2018-11-28 transaction · row 18 Instrument identity requires review; Table II rows are not merged. 1 source row Row 18 · 2018-11-28 · Exercise / conversion · Disposed 76,044 · Balance 0 F5: Vesting of previously reported RSUs granted under the Plan on March 2, 2018.
Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $32.11	Direct	Reported balance After 2018-11-28 transaction · row 19 Instrument identity requires review; Table II rows are not merged. 1 source row Row 19 · 2018-11-28 · Disposition to issuer · Disposed 299,751 · Balance 0 F18: Represents Stock Appreciation Rights ("SARs") granted under the Plan on February 13, 2009. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount (the "SAR Amount") in cash for each SAR equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date, less (c) the exercise price.
Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $72.26	Direct	Reported balance After 2018-11-28 transaction · row 21 Instrument identity requires review; Table II rows are not merged. 1 source row Row 21 · 2018-11-28 · Disposition to issuer · Disposed 304,626 · Balance 0 F20: Represents SARs granted under the Plan on March 3, 2014. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR, equal to the SAR Amount.
Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $100.50	Direct	Reported balance After 2018-11-28 transaction · row 22 Instrument identity requires review; Table II rows are not merged. 1 source row Row 22 · 2018-11-28 · Disposition to issuer · Disposed 253,480 · Balance 0 F21: Represents SARs granted under the Plan on March 2, 2015. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR, equal to the SAR Amount.
Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $103.45	Direct	Reported balance After 2018-11-28 transaction · row 23 Instrument identity requires review; Table II rows are not merged. 1 source row Row 23 · 2018-11-28 · Disposition to issuer · Disposed 253,242 · Balance 0 F22: Represents SARs granted under the Plan on February 19, 2016. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR, equal to the SAR Amount.
Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $125.27	Direct	Reported balance After 2018-11-28 transaction · row 24 Instrument identity requires review; Table II rows are not merged. 1 source row Row 24 · 2018-11-28 · Disposition to issuer · Disposed 260,037 · Balance 0 F23: Represents SARs granted under the Plan on February 17, 2017. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR, equal to the SAR Amount.
Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $64.25	Direct	Reported balance After 2018-11-28 transaction · row 20 Instrument identity requires review; Table II rows are not merged. 1 source row Row 20 · 2018-11-28 · Disposition to issuer · Disposed 500,000 · Balance 0 F19: Represents SARs granted under the Plan on August 5, 2013. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR, equal to the SAR Amount.
Deferred Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2018-11-28 transaction · row 25 Instrument identity requires review; Table II rows are not merged. 1 source row Row 25 · 2018-11-28 · Disposition to issuer · Disposed 74,140.1044 · Balance 0 F24: Represents Deferred Stock Units ("DSUs") previously reported and accrued pursuant to the Plan. These DSUs were canceled for an amount in cash for each DSU equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date.

Filing footnotes · ownership attribution and instrument terms

F1: Vesting of performance stock units ("PSUs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") on February 19, 2016.

F2: Vesting of PSUs granted under the Plan on February 17, 2017.

F3: Vesting of previously reported restricted stock units ("RSUs") granted under the Plan on February 19, 2016.

F4: Vesting of previously reported RSUs granted under the Plan on February 17, 2017.

F5: Vesting of previously reported RSUs granted under the Plan on March 2, 2018.

F6: Represents tax withholding on accelerated vesting of PSUs and RSUs granted under the Plan.

F7: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock.

F8: Represents shares held in Charitable Lead Annuity Trust ("CLAT") for which Reporting Person is the investment advisor.

F9: On August 27, 2018, 51,537 shares were voluntarily transferred from 2017 Grantor Retained Annuity Trust ("GRAT") to the Reporting Person's sole account.

F10: Represents shares held by 2017 GRAT for which Reporting Person is sole trustee.

F11: Represents shares held by 2017 GRAT II for which Reporting Person is sole trustee.

F12: On July 23, 2018, 145,826 shares were distributed to the Reporting Person's sole account to satisfy 2016 GRAT annuity obligation. On July 31, 2018, 259,969 shares were voluntarily transferred from Reporting Person's sole account to 2018 GRAT.

F13: Represents shares held by 2018 GRAT for which Reporting Person is sole trustee

F14: On October 24, 2018, 134,649 shares were transferred from 2016 GRAT to 2016 Trust.

F15: Represents shares held by a 2016 Trust for which Reporting Person is the investment advisor.

F16: On October 24, 2018, 14,961 shares were transferred from 2016 GRAT to 2018 Trust.

F17: Represents shares held by a 2018 Trust for which Reporting Person is the investment advisor.

F18: Represents Stock Appreciation Rights ("SARs") granted under the Plan on February 13, 2009. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount (the "SAR Amount") in cash for each SAR equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date, less (c) the exercise price.

F19: Represents SARs granted under the Plan on August 5, 2013. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR, equal to the SAR Amount.

F20: Represents SARs granted under the Plan on March 3, 2014. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR, equal to the SAR Amount.

F21: Represents SARs granted under the Plan on March 2, 2015. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR, equal to the SAR Amount.

F22: Represents SARs granted under the Plan on February 19, 2016. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR, equal to the SAR Amount.

F23: Represents SARs granted under the Plan on February 17, 2017. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR, equal to the SAR Amount.

F24: Represents Deferred Stock Units ("DSUs") previously reported and accrued pursuant to the Plan. These DSUs were canceled for an amount in cash for each DSU equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
November 28, 2018 Filed Nov 28, 2018 16:31 UTC	AETNA INC /PA/ AET · Entity 107289	Exercise / conversionRestricted Stock Units · Derivative	8,893	$0.00	$0.00	Disclosure SEC source: 0001122304-18-000167 · edgar.xml · derivative · entry 15 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,893 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Vesting of previously reported restricted stock units ("RSUs") granted under the Plan on February 19, 2016. F3 · price: Vesting of previously reported restricted stock units ("RSUs") granted under the Plan on February 19, 2016. F3 · derivative.exercise_date: Vesting of previously reported restricted stock units ("RSUs") granted under the Plan on February 19, 2016. F3 · derivative.expiration_date: Vesting of previously reported restricted stock units ("RSUs") granted under the Plan on February 19, 2016. Read SEC document
November 28, 2018 Filed Nov 28, 2018 16:31 UTC	AETNA INC /PA/ AET · Entity 107289	Disposition to issuerCommon Stock	14,961	Not disclosed	Not disclosed	Disclosure SEC source: 0001122304-18-000167 · edgar.xml · nonDerivative · entry 14 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By 2018 Trust Disclosed balance after: 0 F16 · shares: On October 24, 2018, 14,961 shares were transferred from 2016 GRAT to 2018 Trust. F7 · price: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. F17 · ownership.nature: Represents shares held by a 2018 Trust for which Reporting Person is the investment advisor. Read SEC document
November 28, 2018 Filed Nov 28, 2018 16:31 UTC	AETNA INC /PA/ AET · Entity 107289	Disposition to issuerCommon Stock	134,649	Not disclosed	Not disclosed	Disclosure SEC source: 0001122304-18-000167 · edgar.xml · nonDerivative · entry 13 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By 2016 Trust Disclosed balance after: 0 F14 · shares: On October 24, 2018, 134,649 shares were transferred from 2016 GRAT to 2016 Trust. F7 · price: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. F15 · ownership.nature: Represents shares held by a 2016 Trust for which Reporting Person is the investment advisor. Read SEC document
November 28, 2018 Filed Nov 28, 2018 16:31 UTC	AETNA INC /PA/ AET · Entity 107289	Disposition to issuerCommon Stock	259,969	Not disclosed	Not disclosed	Disclosure SEC source: 0001122304-18-000167 · edgar.xml · nonDerivative · entry 12 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By 2018 GRAT Disclosed balance after: 0 F12 · shares: On July 23, 2018, 145,826 shares were distributed to the Reporting Person's sole account to satisfy 2016 GRAT annuity obligation. On July 31, 2018, 259,969 shares were voluntarily transferred from Reporting Person's sole account to 2018 GRAT. F7 · price: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. F13 · ownership.nature: Represents shares held by 2018 GRAT for which Reporting Person is sole trustee Read SEC document
November 28, 2018 Filed Nov 28, 2018 16:31 UTC	AETNA INC /PA/ AET · Entity 107289	Disposition to issuerCommon Stock	107,576	Not disclosed	Not disclosed	Disclosure SEC source: 0001122304-18-000167 · edgar.xml · nonDerivative · entry 11 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By 2017 GRAT II Disclosed balance after: 0 F7 · price: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. F11 · ownership.nature: Represents shares held by 2017 GRAT II for which Reporting Person is sole trustee. Read SEC document
November 28, 2018 Filed Nov 28, 2018 16:31 UTC	AETNA INC /PA/ AET · Entity 107289	Disposition to issuerCommon Stock	107,098	Not disclosed	Not disclosed	Disclosure SEC source: 0001122304-18-000167 · edgar.xml · nonDerivative · entry 10 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By 2017 GRAT Disclosed balance after: 0 F9 · shares: On August 27, 2018, 51,537 shares were voluntarily transferred from 2017 Grantor Retained Annuity Trust ("GRAT") to the Reporting Person's sole account. F7 · price: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. F10 · ownership.nature: Represents shares held by 2017 GRAT for which Reporting Person is sole trustee. Read SEC document
November 28, 2018 Filed Nov 28, 2018 16:31 UTC	AETNA INC /PA/ AET · Entity 107289	Disposition to issuerCommon Stock	119,447	Not disclosed	Not disclosed	Disclosure SEC source: 0001122304-18-000167 · edgar.xml · nonDerivative · entry 9 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By CLAT Disclosed balance after: 0 F7 · price: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. F8 · ownership.nature: Represents shares held in Charitable Lead Annuity Trust ("CLAT") for which Reporting Person is the investment advisor. Read SEC document
November 28, 2018 Filed Nov 28, 2018 16:31 UTC	AETNA INC /PA/ AET · Entity 107289	Disposition to issuerCommon Stock	169,107	Not disclosed	Not disclosed	Disclosure SEC source: 0001122304-18-000167 · edgar.xml · nonDerivative · entry 8 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F7 · price: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. Read SEC document
November 28, 2018 Filed Nov 28, 2018 16:31 UTC	AETNA INC /PA/ AET · Entity 107289	Tax withholdingCommon Stock	102,990	$209.01	$21,525,939.90	Disclosure SEC source: 0001122304-18-000167 · edgar.xml · nonDerivative · entry 7 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,107 F6 · price: Represents tax withholding on accelerated vesting of PSUs and RSUs granted under the Plan. Read SEC document
November 28, 2018 Filed Nov 28, 2018 16:31 UTC	AETNA INC /PA/ AET · Entity 107289	Exercise / conversionCommon Stock	76,044	$0.00	$0.00	Disclosure SEC source: 0001122304-18-000167 · edgar.xml · nonDerivative · entry 6 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,097 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Vesting of previously reported RSUs granted under the Plan on March 2, 2018. Read SEC document
November 28, 2018 Filed Nov 28, 2018 16:31 UTC	AETNA INC /PA/ AET · Entity 107289	Exercise / conversionCommon Stock	17,572	$0.00	$0.00	Disclosure SEC source: 0001122304-18-000167 · edgar.xml · nonDerivative · entry 5 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,053 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: Vesting of previously reported RSUs granted under the Plan on March 2, 2018. Read SEC document
November 28, 2018 Filed Nov 28, 2018 16:31 UTC	AETNA INC /PA/ AET · Entity 107289	Exercise / conversionCommon Stock	13,220	$0.00	$0.00	Disclosure SEC source: 0001122304-18-000167 · edgar.xml · nonDerivative · entry 4 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,481 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Vesting of previously reported RSUs granted under the Plan on February 17, 2017. Read SEC document
November 28, 2018 Filed Nov 28, 2018 16:31 UTC	AETNA INC /PA/ AET · Entity 107289	Exercise / conversionCommon Stock	8,893	$0.00	$0.00	Disclosure SEC source: 0001122304-18-000167 · edgar.xml · nonDerivative · entry 3 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,261 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Vesting of previously reported restricted stock units ("RSUs") granted under the Plan on February 19, 2016. Read SEC document
November 28, 2018 Filed Nov 28, 2018 16:31 UTC	AETNA INC /PA/ AET · Entity 107289	Exercise / conversionCommon Stock	32,331	$0.00	$0.00	Disclosure SEC source: 0001122304-18-000167 · edgar.xml · nonDerivative · entry 2 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,368 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Vesting of PSUs granted under the Plan on February 17, 2017. Read SEC document
November 28, 2018 Filed Nov 28, 2018 16:31 UTC	AETNA INC /PA/ AET · Entity 107289	Exercise / conversionCommon Stock	72,500	$0.00	$0.00	Disclosure SEC source: 0001122304-18-000167 · edgar.xml · nonDerivative · entry 1 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,037 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Vesting of performance stock units ("PSUs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") on February 19, 2016. Read SEC document
November 28, 2018 Filed Nov 30, 2018 22:24 UTC	CVS HEALTH Corp CVS · Entity 2884	GrantCommon Stock	112,808	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-18-034857 · form4.xml · nonDerivative · entry 8 Bertolini Mark T · CIK 0001352552 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By 2016 Trust Disclosed balance after: 112,808 F2 · price: Pursuant to the terms of the Agreement and Plan of Merger, dated as of December 3, 2017 (the "Merger Agreement"), by and among CVS Health Corporation ("CVS Health"), Hudson Merger Sub Corp. (the "Merger Sub"), a wholly owned subsidiary of CVS Health, and Aetna Inc. ("Aetna"), on November 28, 2018 (the "Closing Date") the Merger Sub merged with and into Aetna (the "Merger"), with Aetna continuing as the surviving company of the Merger and as a wholly owned subsidiary of CVS Health. Pursuant to the Merger Agreement, on the Closing Date each share of Aetna common stock held by the reporting person was converted into the right to receive 0.8378 of a share of common stock of CVS Health and $145.00 in cash. The closing price of CVS Health's common stock on November 28, 2018 was $80.27 per share. F8 · ownership.nature: Represents shares held by a 2016 Trust for which the reporting person is the investment advisor. Read SEC document
November 28, 2018 Filed Nov 30, 2018 22:24 UTC	CVS HEALTH Corp CVS · Entity 2884	GrantCommon Stock	12,534	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-18-034857 · form4.xml · nonDerivative · entry 7 Bertolini Mark T · CIK 0001352552 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By 2018 Trust Disclosed balance after: 12,534 F2 · price: Pursuant to the terms of the Agreement and Plan of Merger, dated as of December 3, 2017 (the "Merger Agreement"), by and among CVS Health Corporation ("CVS Health"), Hudson Merger Sub Corp. (the "Merger Sub"), a wholly owned subsidiary of CVS Health, and Aetna Inc. ("Aetna"), on November 28, 2018 (the "Closing Date") the Merger Sub merged with and into Aetna (the "Merger"), with Aetna continuing as the surviving company of the Merger and as a wholly owned subsidiary of CVS Health. Pursuant to the Merger Agreement, on the Closing Date each share of Aetna common stock held by the reporting person was converted into the right to receive 0.8378 of a share of common stock of CVS Health and $145.00 in cash. The closing price of CVS Health's common stock on November 28, 2018 was $80.27 per share. F7 · ownership.nature: Represents shares held by a 2018 Trust for which the reporting person is the investment advisor. Read SEC document
November 28, 2018 Filed Nov 30, 2018 22:24 UTC	CVS HEALTH Corp CVS · Entity 2884	GrantCommon Stock	217,802	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-18-034857 · form4.xml · nonDerivative · entry 6 Bertolini Mark T · CIK 0001352552 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By 2018 GRAT Disclosed balance after: 217,802 F2 · price: Pursuant to the terms of the Agreement and Plan of Merger, dated as of December 3, 2017 (the "Merger Agreement"), by and among CVS Health Corporation ("CVS Health"), Hudson Merger Sub Corp. (the "Merger Sub"), a wholly owned subsidiary of CVS Health, and Aetna Inc. ("Aetna"), on November 28, 2018 (the "Closing Date") the Merger Sub merged with and into Aetna (the "Merger"), with Aetna continuing as the surviving company of the Merger and as a wholly owned subsidiary of CVS Health. Pursuant to the Merger Agreement, on the Closing Date each share of Aetna common stock held by the reporting person was converted into the right to receive 0.8378 of a share of common stock of CVS Health and $145.00 in cash. The closing price of CVS Health's common stock on November 28, 2018 was $80.27 per share. F6 · ownership.nature: Represents shares held by 2018 GRAT for which the reporting person is the sole trustee. Read SEC document
November 28, 2018 Filed Nov 30, 2018 22:24 UTC	CVS HEALTH Corp CVS · Entity 2884	GrantCommon Stock	90,127	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-18-034857 · form4.xml · nonDerivative · entry 5 Bertolini Mark T · CIK 0001352552 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By 2017 GRAT II Disclosed balance after: 90,127 F2 · price: Pursuant to the terms of the Agreement and Plan of Merger, dated as of December 3, 2017 (the "Merger Agreement"), by and among CVS Health Corporation ("CVS Health"), Hudson Merger Sub Corp. (the "Merger Sub"), a wholly owned subsidiary of CVS Health, and Aetna Inc. ("Aetna"), on November 28, 2018 (the "Closing Date") the Merger Sub merged with and into Aetna (the "Merger"), with Aetna continuing as the surviving company of the Merger and as a wholly owned subsidiary of CVS Health. Pursuant to the Merger Agreement, on the Closing Date each share of Aetna common stock held by the reporting person was converted into the right to receive 0.8378 of a share of common stock of CVS Health and $145.00 in cash. The closing price of CVS Health's common stock on November 28, 2018 was $80.27 per share. F5 · ownership.nature: Represents shares held by 2017 GRAT II for which the reporting person is the sole trustee. Read SEC document
November 28, 2018 Filed Nov 30, 2018 22:24 UTC	CVS HEALTH Corp CVS · Entity 2884	GrantCommon Stock	89,726	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-18-034857 · form4.xml · nonDerivative · entry 4 Bertolini Mark T · CIK 0001352552 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By 2017 GRAT Disclosed balance after: 89,726 F2 · price: Pursuant to the terms of the Agreement and Plan of Merger, dated as of December 3, 2017 (the "Merger Agreement"), by and among CVS Health Corporation ("CVS Health"), Hudson Merger Sub Corp. (the "Merger Sub"), a wholly owned subsidiary of CVS Health, and Aetna Inc. ("Aetna"), on November 28, 2018 (the "Closing Date") the Merger Sub merged with and into Aetna (the "Merger"), with Aetna continuing as the surviving company of the Merger and as a wholly owned subsidiary of CVS Health. Pursuant to the Merger Agreement, on the Closing Date each share of Aetna common stock held by the reporting person was converted into the right to receive 0.8378 of a share of common stock of CVS Health and $145.00 in cash. The closing price of CVS Health's common stock on November 28, 2018 was $80.27 per share. F4 · ownership.nature: Represents shares held by 2017 Grantor Retained Annuity Trust ("GRAT") for which the reporting person is the sole trustee. Read SEC document
November 28, 2018 Filed Nov 30, 2018 22:24 UTC	CVS HEALTH Corp CVS · Entity 2884	GrantCommon Stock	100,072	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-18-034857 · form4.xml · nonDerivative · entry 3 Bertolini Mark T · CIK 0001352552 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By CLAT Disclosed balance after: 100,072 F2 · price: Pursuant to the terms of the Agreement and Plan of Merger, dated as of December 3, 2017 (the "Merger Agreement"), by and among CVS Health Corporation ("CVS Health"), Hudson Merger Sub Corp. (the "Merger Sub"), a wholly owned subsidiary of CVS Health, and Aetna Inc. ("Aetna"), on November 28, 2018 (the "Closing Date") the Merger Sub merged with and into Aetna (the "Merger"), with Aetna continuing as the surviving company of the Merger and as a wholly owned subsidiary of CVS Health. Pursuant to the Merger Agreement, on the Closing Date each share of Aetna common stock held by the reporting person was converted into the right to receive 0.8378 of a share of common stock of CVS Health and $145.00 in cash. The closing price of CVS Health's common stock on November 28, 2018 was $80.27 per share. F3 · ownership.nature: Represents shares held in Charitable Lead Annuity Trust for which the reporting person is the investment advisor. Read SEC document
November 28, 2018 Filed Nov 30, 2018 22:24 UTC	CVS HEALTH Corp CVS · Entity 2884	GrantCommon Stock	141,677	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-18-034857 · form4.xml · nonDerivative · entry 2 Bertolini Mark T · CIK 0001352552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,985 F2 · price: Pursuant to the terms of the Agreement and Plan of Merger, dated as of December 3, 2017 (the "Merger Agreement"), by and among CVS Health Corporation ("CVS Health"), Hudson Merger Sub Corp. (the "Merger Sub"), a wholly owned subsidiary of CVS Health, and Aetna Inc. ("Aetna"), on November 28, 2018 (the "Closing Date") the Merger Sub merged with and into Aetna (the "Merger"), with Aetna continuing as the surviving company of the Merger and as a wholly owned subsidiary of CVS Health. Pursuant to the Merger Agreement, on the Closing Date each share of Aetna common stock held by the reporting person was converted into the right to receive 0.8378 of a share of common stock of CVS Health and $145.00 in cash. The closing price of CVS Health's common stock on November 28, 2018 was $80.27 per share. Read SEC document
November 28, 2018 Filed Nov 30, 2018 22:24 UTC	CVS HEALTH Corp CVS · Entity 2884	GrantCommon Stock	1,308	$80.27	$104,993.16	Disclosure SEC source: 0001127602-18-034857 · form4.xml · nonDerivative · entry 1 Bertolini Mark T · CIK 0001352552 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,308 F1 · shares: Consists of common stock issued as a pro rata portion of the retainer payable for the reporting person's 2018-2019 Board service, pursuant to the Registrant's 2017 Incentive Compensation Plan. Read SEC document
March 28, 2018 Filed Mar 30, 2018 17:13 UTC	AETNA INC /PA/ AET · Entity 107289	GiftCommon Stock	189,785	$0.00	$0.00	Disclosure SEC source: 0001122304-18-000045 · edgar.xml · nonDerivative · entry 1 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,143 Read SEC document
March 06, 2018 Filed Mar 8, 2018 20:06 UTC	VERIZON COMMUNICATIONS INC VZ · Entity 116	GrantPhantom Stock · Derivative	3,579	$0.00	$0.00	Disclosure SEC source: 0001611593-18-000057 · edgar.xml · derivative · entry 1 Bertolini Mark T · CIK 0001352552 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Deferred Compensation Plan Disclosed balance after: 17,143 Underlying: Common Stock · 3,579 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock and is settled in cash. The shares of phantom stock become payable following the reporting person's termination of service as a director. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock and is settled in cash. The shares of phantom stock become payable following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock and is settled in cash. The shares of phantom stock become payable following the reporting person's termination of service as a director. F2 · balance_after: Includes phantom stock acquired through dividend reinvestment. Read SEC document
March 02, 2018 Filed Mar 6, 2018 16:12 UTC	AETNA INC /PA/ AET · Entity 107289	GrantRestricted Stock Units · Derivative	17,572	$0.00	$0.00	Disclosure SEC source: 0001122304-18-000028 · edgar.xml · derivative · entry 12 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,572 Underlying: Common Stock · 17,572 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a right to receive one share of Aetna Inc. Common Stock net of taxes. F14 · derivative.exercise_date: RSUs granted under the Plan vest in three annual installments beginning March 2, 2019. F14 · derivative.expiration_date: RSUs granted under the Plan vest in three annual installments beginning March 2, 2019. Read SEC document
March 02, 2018 Filed Mar 6, 2018 16:12 UTC	AETNA INC /PA/ AET · Entity 107289	GrantRestricted Stock Units · Derivative	76,044	$0.00	$0.00	Disclosure SEC source: 0001122304-18-000028 · edgar.xml · derivative · entry 11 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,044 Underlying: Common Stock · 76,044 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a right to receive one share of Aetna Inc. Common Stock net of taxes. F13 · derivative.exercise_date: RSUs granted under the Plan vest in three annual installments beginning December 2, 2018. F13 · derivative.expiration_date: RSUs granted under the Plan vest in three annual installments beginning December 2, 2018. Read SEC document
March 02, 2018 Filed Mar 6, 2018 16:12 UTC	AETNA INC /PA/ AET · Entity 107289	Exercise / conversionPerformance Stock Units · Derivative	34,329	$0.00	$0.00	Disclosure SEC source: 0001122304-18-000028 · edgar.xml · derivative · entry 10 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,329 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each PSU represents a right to receive up to two shares of Aetna Inc. Common Stock net of taxes. F12 · derivative.exercise_date: PSUs granted under the Plan. F12 · derivative.expiration_date: PSUs granted under the Plan. Read SEC document
March 02, 2018 Filed Mar 6, 2018 16:12 UTC	AETNA INC /PA/ AET · Entity 107289	Exercise / conversionRestricted Stock Units · Derivative	8,358	$0.00	$0.00	Disclosure SEC source: 0001122304-18-000028 · edgar.xml · derivative · entry 9 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,358 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a right to receive one share of Aetna Inc. Common Stock net of taxes. F11 · derivative.exercise_date: RSUs granted under the Plan. F11 · derivative.expiration_date: RSUs granted under the Plan. Read SEC document
March 02, 2018 Filed Mar 6, 2018 16:12 UTC	AETNA INC /PA/ AET · Entity 107289	Tax withholdingCommon Stock	18,683	$177.53	$3,316,792.99	Disclosure SEC source: 0001122304-18-000028 · edgar.xml · nonDerivative · entry 4 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,928 F6 · shares: Represents tax withholding on vesting of previously reported PSUs. Read SEC document
March 02, 2018 Filed Mar 6, 2018 16:12 UTC	AETNA INC /PA/ AET · Entity 107289	Exercise / conversionCommon Stock	41,195	Not disclosed	Not disclosed	Disclosure SEC source: 0001122304-18-000028 · edgar.xml · nonDerivative · entry 3 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,611 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents vesting of previously reported Performance Stock Units ("PSUs") granted under the Plan. F5 · price: Each PSU represents a right to receive up to two shares of Aetna Inc. Common Stock net of taxes. Read SEC document
March 02, 2018 Filed Mar 6, 2018 16:12 UTC	AETNA INC /PA/ AET · Entity 107289	Tax withholdingCommon Stock	3,791	$177.53	$673,016.23	Disclosure SEC source: 0001122304-18-000028 · edgar.xml · nonDerivative · entry 2 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,416 F3 · shares: Represents tax withholding on vesting of previously reported RSUs. Read SEC document
March 02, 2018 Filed Mar 6, 2018 16:12 UTC	AETNA INC /PA/ AET · Entity 107289	Exercise / conversionCommon Stock	8,358	Not disclosed	Not disclosed	Disclosure SEC source: 0001122304-18-000028 · edgar.xml · nonDerivative · entry 1 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,207 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of previously reported Restricted Stock Units ("RSUs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan"). F2 · price: Each RSU represents a right to receive one share of Aetna Inc. Common Stock net of taxes. Read SEC document
February 20, 2018 Filed Feb 22, 2018 16:14 UTC	AETNA INC /PA/ AET · Entity 107289	Exercise / conversionRestricted Stock Units · Derivative	8,893	$0.00	$0.00	Disclosure SEC source: 0001122304-18-000023 · edgar.xml · derivative · entry 9 Bertolini Mark T · CIK 0001352552 · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,893 Underlying: Common Stock · 8,893 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a right to receive one share of Aetna Inc. Common Stock net of taxes. F4 · derivative.exercise_date: Restricted Stock Units previously granted under the Plan. F4 · derivative.expiration_date: Restricted Stock Units previously granted under the Plan. Read SEC document
February 20, 2018 Filed Feb 22, 2018 16:14 UTC	AETNA INC /PA/ AET · Entity 107289	Exercise / conversionRestricted Stock Units · Derivative	6,610	$0.00	$0.00	Disclosure SEC source: 0001122304-18-000023 · edgar.xml · derivative · entry 8 Bertolini Mark T · CIK 0001352552 · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,220 Underlying: Common Stock · 6,610 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a right to receive one share of Aetna Inc. Common Stock net of taxes. F4 · derivative.exercise_date: Restricted Stock Units previously granted under the Plan. F4 · derivative.expiration_date: Restricted Stock Units previously granted under the Plan. Read SEC document
February 20, 2018 Filed Feb 22, 2018 16:14 UTC	AETNA INC /PA/ AET · Entity 107289	Tax withholdingCommon Stock	7,031	$178.03	$1,251,728.93	Disclosure SEC source: 0001122304-18-000023 · edgar.xml · nonDerivative · entry 3 Bertolini Mark T · CIK 0001352552 · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,849 F3 · shares: Represents tax withholding on vesting of previously reported Restricted Stock Units. Read SEC document
February 20, 2018 Filed Feb 22, 2018 16:14 UTC	AETNA INC /PA/ AET · Entity 107289	Exercise / conversionCommon Stock	8,893	Not disclosed	Not disclosed	Disclosure SEC source: 0001122304-18-000023 · edgar.xml · nonDerivative · entry 2 Bertolini Mark T · CIK 0001352552 · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,880 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of previously reported Restricted Stock Units granted under the 2010 Stock Incentive Plan (the "Plan"). F2 · price: Each Restricted Stock Unit represents a right to receive one share of Aetna Inc. Common Stock net of taxes. Read SEC document
February 20, 2018 Filed Feb 22, 2018 16:14 UTC	AETNA INC /PA/ AET · Entity 107289	Exercise / conversionCommon Stock	6,610	Not disclosed	Not disclosed	Disclosure SEC source: 0001122304-18-000023 · edgar.xml · nonDerivative · entry 1 Bertolini Mark T · CIK 0001352552 · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,987 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of previously reported Restricted Stock Units granted under the 2010 Stock Incentive Plan (the "Plan"). F2 · price: Each Restricted Stock Unit represents a right to receive one share of Aetna Inc. Common Stock net of taxes. Read SEC document
February 05, 2018 Filed Feb 7, 2018 16:09 UTC	AETNA INC /PA/ AET · Entity 107289	Exercise / conversionStock Appreciation Right · Derivative	197,897	$50.70 Strike: $50.70	$10,033,377.90	Disclosure SEC source: 0001122304-18-000015 · edgar.xml · derivative · entry 7 Bertolini Mark T · CIK 0001352552 · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 197,897 shares Expires 2018-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 05, 2018 Filed Feb 7, 2018 16:09 UTC	AETNA INC /PA/ AET · Entity 107289	Tax withholdingCommon Stock	119,305	$180.95	$21,588,239.75	Disclosure SEC source: 0001122304-18-000015 · edgar.xml · nonDerivative · entry 2 Bertolini Mark T · CIK 0001352552 · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,377 F1 · price: Stock Appreciation Right is net settled; amount represents withholding of shares by the Company to pay exercise price and taxes. Read SEC document
February 05, 2018 Filed Feb 7, 2018 16:09 UTC	AETNA INC /PA/ AET · Entity 107289	Exercise / conversionCommon Stock	197,897	$50.70	$10,033,377.90	Disclosure SEC source: 0001122304-18-000015 · edgar.xml · nonDerivative · entry 1 Bertolini Mark T · CIK 0001352552 · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 387,682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 19, 2017 Filed Dec 21, 2017 16:18 UTC	AETNA INC /PA/ AET · Entity 107289	GrantPerformance Stock Units · Derivative	34,329	$0.00	$0.00	Disclosure SEC source: 0001122304-17-000131 · edgar.xml · derivative · entry 1 Bertolini Mark T · CIK 0001352552 · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,329 Underlying: Common Stock · 34,329 shares Expires not disclosed F1 · derivative.exercise_price: Performance Stock Units ("PSUs") granted under the Aetna Inc. 2010 Stock Incentive Plan. Each PSU represents a right to receive up to two shares of Aetna Inc. Common Stock net taxes, depending on performance against the specified Company performance target. F2 · derivative.exercise_date: PSUs originally granted on March 2, 2015. Units vest based on both service through March 2, 2018 and attaining the specified Company performance target. On December 19, 2017, the Company's Committee on Compensation and Talent Management determined that the performance target had been met at a specified level for the performance period. Units will fully vest in accordance with the Plan if executive remains employed by the Company through March 2, 2018. F2 · derivative.expiration_date: PSUs originally granted on March 2, 2015. Units vest based on both service through March 2, 2018 and attaining the specified Company performance target. On December 19, 2017, the Company's Committee on Compensation and Talent Management determined that the performance target had been met at a specified level for the performance period. Units will fully vest in accordance with the Plan if executive remains employed by the Company through March 2, 2018. Read SEC document
December 13, 2017 Filed Dec 15, 2017 16:08 UTC	AETNA INC /PA/ AET · Entity 107289	GiftCommon Stock	53,885	$0.00	$0.00	Disclosure SEC source: 0001122304-17-000129 · edgar.xml · nonDerivative · entry 2 Bertolini Mark T · CIK 0001352552 · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,785 Read SEC document
December 06, 2017 Filed Dec 15, 2017 16:08 UTC	AETNA INC /PA/ AET · Entity 107289	GiftCommon Stock	553	$0.00	$0.00	Disclosure SEC source: 0001122304-17-000129 · edgar.xml · nonDerivative · entry 1 Bertolini Mark T · CIK 0001352552 · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By CLAT Disclosed balance after: 119,447 F1 · ownership.nature: Represents shares held by Charitable Lead Annuity Trust ("CLAT") where Reporting Person is investment advisor. Read SEC document
May 17, 2017 Filed May 18, 2017 16:49 UTC	AETNA INC /PA/ AET · Entity 107289	SaleCommon Stock	1,520	$141.27	$214,733.90	Disclosure SEC source: 0001122304-17-000046 · edgar.xml · nonDerivative · entry 4 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,246 F3 · price: The price reported is average weighted share price. These shares were sold in multiple transactions at prices ranging from $141.24 to $141.35, inclusive. Read SEC document
May 17, 2017 Filed May 18, 2017 16:49 UTC	AETNA INC /PA/ AET · Entity 107289	SaleCommon Stock	102,027	$140.78	$14,363,789.57	Disclosure SEC source: 0001122304-17-000046 · edgar.xml · nonDerivative · entry 3 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352,766 F2 · price: The price reported is average weighted share price. These shares were sold in multiple transactions at prices ranging from $140.24 to $141.235, inclusive. Read SEC document
May 16, 2017 Filed May 18, 2017 16:49 UTC	AETNA INC /PA/ AET · Entity 107289	Exercise / conversionStock Appreciation Right · Derivative	308,642	$48.65 Strike: $48.65	$15,015,433.30	Disclosure SEC source: 0001122304-17-000046 · edgar.xml · derivative · entry 8 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 308,642 shares Expires 2017-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 16, 2017 Filed May 18, 2017 16:49 UTC	AETNA INC /PA/ AET · Entity 107289	Tax withholdingCommon Stock	205,095	$141.86	$29,094,776.70	Disclosure SEC source: 0001122304-17-000046 · edgar.xml · nonDerivative · entry 2 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 454,793 F1 · price: Stock Appreciation Right is net settled; amount represents withholding of shares by the Company to pay exercise price and taxes. Read SEC document
May 16, 2017 Filed May 18, 2017 16:49 UTC	AETNA INC /PA/ AET · Entity 107289	Exercise / conversionCommon Stock	308,642	$48.65	$15,015,433.30	Disclosure SEC source: 0001122304-17-000046 · edgar.xml · nonDerivative · entry 1 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 659,888 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 03, 2017 Filed Mar 6, 2017 16:28 UTC	AETNA INC /PA/ AET · Entity 107289	Exercise / conversionPerformance Stock Units · Derivative	41,517	$0.00	$0.00	Disclosure SEC source: 0001122304-17-000023 · edgar.xml · derivative · entry 11 Bertolini Mark T · CIK 0001352552 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 41,517 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each Performance Stock Unit represents a right to receive up to two shares of Aetna Inc. Common Stock net of taxes. F8 · derivative.exercise_date: Performance Stock Units granted under the Plan. F8 · derivative.expiration_date: Performance Stock Units granted under the Plan. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.